Elevated CETP activity during acute phase of myocardial infarction is independently associated with endothelial

Luiz Sergio F Carvalho1, Vitor W M Virginio2, Natalia B Panzoldo2

  • 1Cardiology Division, State University of Campinas School of Medicine (Unicamp), Campinas, SP, Brazil.

Atherosclerosis
|December 3, 2014
PubMed

Insights

Elevated cholesteryl ester transfer protein (CETP) activity in ST-elevation myocardial infarction (STEMI) patients is linked to endothelial dysfunction and worse clinical outcomes, including sudden death and recurrent heart attacks.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Clinical Research

Background:

  • Cholesteryl ester transfer protein (CETP) activity may be influenced by acute stress, inflammation, oxidative stress, and thrombosis.
  • Previous research suggests a potential link between CETP activity and adverse cardiovascular events.

Purpose of the Study:

  • To investigate the association between CETP activity and inflammatory-oxidative response, thrombogenesis, and clinical outcomes in patients with ST-elevation myocardial infarction (STEMI).

Main Methods:

  • 116 STEMI patients were enrolled within 24 hours of symptom onset and followed for 180 days.
  • Plasma levels of inflammatory markers (CRP, IL-2, TNFα), oxidative stress markers (8-isoprostane, NOx), and CETP activity were measured.
  • Flow-mediated dilation (FMD) and coronary thrombus burden (CTB) were assessed.

Main Results:

  • Higher baseline CETP activity was associated with reduced nitric oxide (NOx) levels and lower FMD.
  • Increased thiobarbituric acid reactive substances (TBARS) in HDL particles correlated with CETP activity and impaired FMD.
  • High CETP activity at admission predicted sudden death and recurrent myocardial infarction (MI) within 30 and 180 days.

Conclusions:

  • Enhanced CETP activity during the acute phase of STEMI is an independent predictor of endothelial dysfunction.
  • Elevated CETP activity is associated with adverse clinical outcomes in STEMI patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
813
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.9K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
789
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
628
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
472